The point is that, yeah its useful for those purposes. But the cost vs benefit don't seem to be inline
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025